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ABSTRACT Mammalian 5-lipoxygenase (5-LO) catalyzes conversion of arachidonic acid to leukotrienes, potent mediators of
inﬂammation and allergy. Upon cell stimulation, 5-LO selectively binds to nuclear membranes and becomes activated, yet the
mechanism of recruitment of 5-LO to nuclear membranes and the mode of 5-LO-membrane interactions are poorly understood.
Here we show that membrane ﬂuidity is an important determinant of membrane binding strength of 5-LO, penetration into the
membrane hydrophobic core, and activity of the enzyme. The membrane binding strength and activity of 5-LO increase with the
degree of lipid acyl chain cis-unsaturation and reach a plateau with 1-palmitoyl-2-arachidonolyl-sn-glycero-3-phosphocholine
(PAPC). A fraction of tryptophans of 5-LO penetrate into the hydrocarbon region of ﬂuid PAPC membranes, but not into solid
1,2-dipalmitoyl-sn-glycero-3-phosphocholine membranes. Our data lead to a novel concept of membrane binding and activation
of 5-LO, suggesting that arachidonic-acid-containing lipids, which are present in nuclear membranes at higher fractions than in
other cellular membranes, may facilitate preferential membrane binding and insertion of 5-LO through increased membrane
ﬂuidity and may thereby modulate the activity of the enzyme. The data presented in this article and earlier data allow
construction of a model for membrane-bound 5-LO, including the angular orientation and membrane insertion of the protein.
INTRODUCTION
Lipoxygenase (LO) is a nonheme, iron-containing enzyme
that catalyzes oxygenation of polyunsaturated fatty acids
(Ku¨hn, 1999; Peters-Golden and Brock, 2003). Both plant
and mammalian LOs have been shown to undergo
functionally important, Ca21-regulated binding to mem-
branes, followed by production of lipid-derived bioactive
mediators (Rouzer and Kargman, 1988; Brock et al., 1995;
Tatulian et al., 1998; Hammarberg et al., 2000; Walther et al.,
2004). Mammalian 5-lipoxygenase (5-LO) is of exceptional
importance because it converts arachidonic acid (AA) to 5-
hydroperoxyeicosatetraenoic acid (5-HPETE) and then to
leukotriene A4, a key intermediate in biosynthesis of all
leukotrienes that act as potent mediators of allergy, in-
ﬂammation, apoptosis, and tumorigenesis (Ghosh and
Myers, 1999; Ra˚dmark, 2000; Chen et al., 2003; Goodarzi
et al., 2003; Fan et al., 2004). Leukotriene production in
stimulated myeloid cells is preceded by a Ca21-mediated
binding of 5-LO to nuclear membranes (Rouzer and
Kargman, 1988; Wong et al., 1991; Malaviya et al., 1993;
Woods et al., 1993; Brock et al., 1995; Pouliot et al., 1996).
A Ca21-independent, phosphorylation-mediated 5-LO trans-
location to the nuclear membrane and activation has also
been documented (Werz et al., 2000, 2002). Although the
role of membrane binding in 5-LO function is well
established, the mode of membrane binding of 5-LO and
the reason for localization to the nuclear membrane remain
poorly understood.
Preferential binding of 5-LO to nuclear membranes might
be due to speciﬁc interactions between 5-LO and intrinsic
proteins of nuclear membranes, such as 5-lipoxygenase ac-
tivating protein (FLAP), an integral protein in nuclear mem-
branes that signiﬁcantly increases 5-LO activity (Reid et al.,
1990; Abramovitz et al., 1993; Pouliot et al., 1996). How-
ever, 5-LO binding to nuclear membranes turned out to be
FLAP-independent (Woods et al., 1995; Peters-Golden and
Brock, 2003). In addition, artiﬁcial lipid membranes or cell
plasma membranes were able to activate 5-LO in the absence
of FLAP (Puustinen et al., 1988; Noguchi et al., 1994; Skorey
and Gresser, 1998; Reddy et al., 2000; Pande et al., 2004),
implying that FLAP is not a molecular determinant for
nuclear membrane localization of 5-LO.
Among a large number of lipids examined, phosphatidyl-
choline (PC) turned out to be the most efﬁcient naturally
occurring lipid in terms of supporting 5-LO activity
(Puustinen et al., 1988; Noguchi et al., 1994; Pande et al.,
2004). The increased afﬁnity of the N-terminal putative
b-barrel domain of 5-LO for PC membranes compared to
membranes containing phosphatidylglycerol (PG) or phos-
phatidylserine (PS) led Kulkarni et al. (2002) to conclude
that high afﬁnity of 5-LO for PC determines its selective
translocation to PC-rich nuclear membranes. However, the
facts that the b-barrel domain of 5-LO binds to PC more
strongly than to anionic lipids and that PC supports 5-LO
activity better than the anionic lipids cannot account for
nuclear membrane targeting of 5-LO for two reasons. First,
comparative analysis of the lipid composition of mammalian
cell membranes indicated similar fractions of PC (42–48%)
in the nuclear and other organellar membranes, including
plasma membranes (Surette and Chilton, 1998; D’Antuono
et al., 2000). Second, nuclear membranes contain large
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fractions of anionic lipids, including PS, PG, cardiolipin,
phosphatidic acid, phosphatidylinositol and its mono- and
bis-phosphates (Khandwala and Kasper, 1971; Neitcheva
and Peeva, 1995; Surette and Chilton, 1998; D’Santos et al.,
1999, 2000; D’Antuono et al., 2000). In fact, in human
leukemia cells the (phosphatidylinositol 1 PS) fraction was
higher in the nuclear membrane (25%) than in the whole-cell
lipid extract (18%) (Surette and Chilton, 1998).
The effects of the lipid hydrocarbon chain composition
and membrane ﬂuidity on 5-LO binding and activity have
not been studied. In this work, we demonstrate a signiﬁcant
stimulatory effect of membrane ﬂuidity on membrane
binding and activity of recombinant human 5-LO. Experi-
ments with PCs in which the number of cis-unsaturated
bonds in the sn-2 acyl chain increases from zero to six
indicate that both membrane binding strength and 5-LO
activity reach a maximum level with membranes composed
of 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine
(PAPC). Moreover, membrane depth-dependent tryptophan
(Trp) ﬂuorescence quenching by brominated lipids shows
that side chains of certain tryptophans of 5-LO signiﬁcantly
penetrate into the interior of ﬂuid PAPC membranes,
whereas no penetration occurs into solid 1,2-dipalmitoyl-sn-
glycero-3-phosphocholine (DPPC) membranes. Our results
lead to a novel concept of membrane-mediated activation of
5-LO, implying that membrane ﬂuidity supports 5-LO
activity by facilitating insertion of the enzyme into the
hydrocarbon region of the membrane. Considering that the
nuclear membranes of various mammalian cells, including
leukocytes, are enriched in AA-containing lipids more than
other subcellular membranes (Neufeld et al., 1985; Capriotti
et al., 1988; Albi et al., 1997; Surette and Chilton, 1998;
D’Antuono et al., 2000), which results in increased ﬂuidity
of nuclear membranes (Yu et al., 1996; Albi et al., 1997;
D’Antuono et al., 2000), our ﬁndings suggest that membrane
ﬂuidity may play a central role in nuclear membrane targeting
and activation of 5-LO.
MATERIALS AND METHODS
Materials
Arachidonic acid was supplied by Cayman Chemical (Ann Arbor, MI). All
lipids were synthetic, and cholesterol was puriﬁed from egg yolk; they all
were purchased from Avanti Polar Lipids (Alabaster, AL). Most of the
chemicals were purchased from Sigma (St. Louis, MO), unless speciﬁed
otherwise, and the sources of other supplies are indicated below. The 5-LO
plasmid, pT3-5LO, was kindly provided by Prof. Ying Yi Zhang (Boston
University School of Medicine), and has been described by Zhang et al.
(1992).
Expression and puriﬁcation of 5-LO
Subcloning of the 5-LO gene into the expression vector pET-21a(1), as well
as protein expression in E. coli BL21(DE3) cells and puriﬁcation, were
conducted as described previously (Pande et al., 2004). The protocol allows
production of highly pure and active recombinant 5-LO that contains a 1:1
stoichiometric amount of iron cofactor. The pure protein eluted from the
ﬁnal size-exclusion Superdex-75 column was pooled, placed into a buffer
containing 150 mM NaCl, 0.1 mM EGTA, 50 mM Tris-HCl (pH 7.5) using
a G-25 desalting column, and used immediately for activity experiments.
Alternatively, the protein was placed in pure deionized water by the same
method, lyophilized, and stored at 80C for biophysical experiments,
which were carried out during the next 2 days. The activity of the lyophilized
5-LO was sustained at the level of ;80% over a period of several days at
80C.
5-LO activity assay
5-LO activity was measured in an assay buffer containing 31.64 mM
Na2HPO4, 5.4 mM KH2PO4, 0.2 mM ATP, 0.1 mM dithiothreitol, 0.1 mM
EGTA, and 0.3 mM CaCl2 (pH 7.5), in the presence of large (100 nm in
diameter) unilamellar vesicles, at 22C, essentially as described previously
(Pande et al., 2004). Vesicles were prepared using a Liposofast extruder
(Avestin, Ottawa, Canada), as described (Pande et al., 2004). 5-LO-
catalyzed conversion of AA to 5-HPETE was monitored by recording time
dependence of absorption at 238 nm, using a Cary 100 double-beam
spectrophotometer (Varian, Palo Alto, CA). The speciﬁc activity of 5-LO
was measured using an extinction coefﬁcient of e238 ¼ 23 mM1 cm1
(Percival, 1991; Skorey and Gresser, 1998). Protein concentration was
measured by Bradford assay (Bradford, 1976).
Measurements of membrane ﬂuidity
Membrane ﬂuidity was evaluated by generalized polarization (GP) of 6-
lauroyl-2-(N,N-dimethylamino)-naphthalene (Laurdan) incorporated in ves-
icle membranes at 1 mol %. Laurdan can be excited at 350–360 nm, and its
emission spectra shift with increasing membrane ﬂuidity, resulting in
a decrease in GP¼ (F435 F500)/(F4351 F500), where F435 and F500 are the
ﬂuorescence emission intensities at respective wavelengths (Parasassi et al.,
1994; Harris et al., 2002; Nyholm et al., 2003). Steady-state ﬂuorescence
spectra were recorded on a Jasco-810 spectroﬂuoropolarimeter (Jasco,
Tokyo, Japan). This is a spectropolarimeter with an additional photo-
multiplier tube mounted at 90 with respect to the incident light beam for
ﬂuorescence measurements. Fluorescence measurements were conducted
using a 0.4-cm path-length quartz cuvette at 22C, maintained by a Peltier
temperature controller. The excitation and emission slits were 4 nm and
10 nm, respectively. The emission spectra of samples containing vesicles in
a buffer of 0.1 mM EGTA, 0.3 mM CaCl2, 50 mM Tris-HCl (pH 7.5) were
measured between 390 and 560 nm, using excitation at 360 nm. The total
lipid concentration was 0.1 mM. The emission spectra were used to calculate
the Laurdan GP, which was used as a measure of membrane ﬂuidity.
Membrane binding measurements by
ﬂuorescence spectroscopy
Binding of 5-LO to vesicle membranes was measured by resonance energy
transfer (RET) from Trp residues of 5-LO to 1,2-dioleoyl-sn-glycero-3-
phosphoethanolamine-N-(1-pyrenesulfonyl) (Py-PE), which was incorpo-
rated in vesicle membranes at 2 mol %. Large unilamellar vesicles were
titrated into the protein solution, with continuous stirring, to yield a total
lipid concentration from 4 to 760 mM. The concentration of 5-LO was
0.2 mM. After each addition of vesicles, the sample was equilibrated for
2 min and ﬂuorescence emission spectra were recorded using a J-810
spectroﬂuoropolarimeter, described above. Temperature was maintained at
22C. The excitation wavelength was 290 nm. Parallel control experiments
were conducted in which vesicles without Py-PE were used to titrate protein
solutions. In these control experiments, addition of lipid vesicles to the
protein solution resulted in a decrease in the measured Trp ﬂuorescence
intensity due to sample dilution. In RET experiments with Py-PE-labeled
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vesicles, the Trp emission intensity signiﬁcantly decreased upon addition of
vesicles due to protein-membrane interactions and energy transfer from Trp
to Py-PE. Analysis of RET data and determination of membrane binding
parameters of 5-LO were conducted as described (Qin et al., 2004). Brieﬂy,
changes in Trp emission intensity at 330 nm (DF) were measured at each
lipid concentration, corrected for the changes in the ﬂuorescence emission as
measured in control experiments, and plotted against DF/[L], where [L] is
the lipid concentration. Each of these Scatchard plots was extrapolated with
a straight line, which was used to determine the saturating value of DF at
high lipid concentrations (DFmax) and the lipid concentration corresponding
to DF ¼ ½DFmax ([L]1/2), respectively from the DF-axis intercept and the
slope of the plot. The experimental binding data were presented as the
dependence of DF/DFmax on [L]. We have shown previously (Qin et al.,
2004) that a simple binding model, suggesting that the membrane surface
contains a ﬁnite number of binding sites that can be either free or occupied
by a protein molecule, leads to the following binding isotherm:
DFrel ¼ b
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
b
2  d½L
N½P
s
; (1)
where b [
1
2
11
d½L
N½P1
KD
½P
 
:
In Eq. 1, DFrel[ DF/DFmax, KD is the dissociation constant, N is the number
of lipid molecules corresponding to a protein binding site, [P] is the total
protein concentration, and d is the fraction of protein-accessible lipid. It has
also been shown in the same source that
KD ¼ d
N
½L1=2 
½P
2
: (2)
In Eq. 2, the total protein concentration, [P], is known, [L]1/2 can be
determined experimentally, as described above, and the fraction of protein-
accessible lipid in the external leaﬂet of 100-nm (in diameter) vesicles with
membrane thickness of ;4 nm (Vogel et al., 2000) is d  0.52. Insertion of
the expression for KD from Eq. 2 into Eq. 1 yields an equation with only one
unknown, i.e., N. The parameter N was varied within physically reasonable
limits and theoretical binding isotherms were simulated through Eq. 1 until
a best ﬁt was achieved between the experimental and theoretical isotherms.
This was followed by calculation of KD through Eq. 2, using the best-ﬁt
value of N.
Tryptophan ﬂuorescence quenching by
brominated or nitroxide-labeled lipids
The degree of insertion of tryptophans into membranes was determined by
measuring the quenching of Trp ﬂuorescence of 5-LO by 1-palmitoyl-2-
stearoyl(dibromo)-sn-glycero-3-phosphocholines (Br2PCs) brominated at
6,7, or 9,10, or 11,12 positions of the acyl chains, or by 1-palmitoyl-2-
oleoyl-sn-glycero-3-phosphotempocholine (POPTC) nitroxide spin-labeled
at the polar headgroup. First, the spectra of free 5-LO (0.24 mM in a buffer
containing 0.1 mM EGTA, 0.3 mM CaCl2, and 50 mM Tris-HCl, pH 7.5)
were measured between 300 and 400 nm, using a 0.4-cm optical path length
quartz cuvette and an excitation wavelength of 290 nm. Then, large
unilamellar vesicles were combined with 5-LO solutions to achieve the same
5-LO concentration and a ﬁnal lipid concentration of 750 mM, and
ﬂuorescence emission spectra were measured. Experiments were conducted
using a ﬂuid lipid, PAPC, and a solid lipid, DPPC. In each case, vesicles of
ﬁve distinct lipid compositions were prepared, i.e., plain lipid without any
quencher, vesicles containing Br2PC brominated at 6,7, or 9,10, or 11,12
positions, and vesicles containing POPTC. Quenching efﬁciencies were
calculated as F0/F, where F0 and F are peak ﬂuorescence intensities in the
absence and presence of the quencher, respectively. Brominated lipids were
present at 25 mol %, and POPTC at 15 mol %. Spectra measured in the
presence of 5-LO were corrected by subtracting the spectra measured under
identical conditions but without 5-LO.
RESULTS
Dependence of 5-LO activity on membrane ﬂuidity
Recently we have analyzed the effect of lipid polar head-
groups on 5-LO-membrane interactions and 5-LO activity
(Pande et al., 2004). The results suggested that the effects of
different lipids on the membrane binding and activity of 5-
LO might be exerted through modulation of both membrane
surface properties and overall membrane structure, including
lipid packing order. In this current work, we have tested the
hypothesis that membrane ﬂuidity and increased fractions
of AA-containing lipids in membranes may promote 5-LO
binding and activity. The activity of 5-LO was measured in
the presence of PCs containing a palmitoyl residue at the
sn-1 position and fatty acid residues with zero to six cis-
unsaturated bonds (nD) at the sn-2 position, i.e., DPPC, 1-
palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC),
1-palmitoyl-2-linoleoyl-sn-glycero-3-phosphocholine (PLPC),
PAPC, and 1-palmitoyl-2-docosahexaenoyl-sn-glycero-3-
phosphocholine (PDPC). Membranes containing lipids with
unsaturated hydrocarbon chains had a signiﬁcant stimulatory
effect on 5-LO activity. The activity of 5-LO, as measured
using the initial slope of the time dependence of absorbance
at 238 nm, due to 5-HPETE production (Percival, 1991;
Skorey and Gresser, 1998), increased ;2.5 times just by
incorporation of a single cis-unsaturated bond in the sn-2
acyl chain of the lipid, i.e., by replacing DPPC with POPC
(Fig. 1 A). Phosphatidylcholines with 2, 4, and 6 cis-double
bonds in their sn-2 acyl chains, i.e., PLPC, PAPC, and
PDPC, resulted in further increase in 5-LO activity, indi-
cating a correlation between the degree of lipid acyl chain
unsaturation and 5-LO activity. It is known that cis-un-
saturation of lipid acyl chains decreases lipid packing order
in membranes and increases membrane ﬂuidity (Stubbs
et al., 1981; Keough et al., 1987; Cevc, 1991), and cho-
lesterol is able to partially reverse this effect (de Almeida
et al., 2003). Incorporation of 20 mol % cholesterol into
POPC membranes signiﬁcantly reduced 5-LO activity com-
pared to that measured in the presence of pure POPC vesicles
(Fig. 1 A), suggesting that the effect of lipid acyl chain cis-
unsaturation on 5-LO activity is probably exerted through
membrane ﬂuidity. The initial slopes of kinetic curves of
5-LO activity were used to calculate the amount of 5-HPETE
production per mg of 5-LO per minute (Fig. 1 B). Data of
Fig. 1, A and B, imply that 5-LO activity is signiﬁcantly pro-
moted in the presence of vesicles composed of lipids with an
increasing degree of unsaturation.
It has been shown previously that membranes composed
of anionic lipids failed to support 5-LO activity as efﬁciently
as PC (Puustinen et al., 1988; Noguchi et al., 1994; Pande
et al., 2004). Here we show that the effect of the anionic
charge of membrane lipids on 5-LO activity depends on
the degree of lipid acyl chain unsaturation. Data of Fig. 2
demonstrate that an increase in the fraction of anionic
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol (POPG)
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in zwitterionic POPC membranes from 0 to 1 causes less
than a twofold impairment in 5-LO activity, whereas similar
fractions of 1,2-dipalmitoyl-sn-glycero-3-phosphoglycerol
(DPPG) in DPPC membranes exerts a fourfold inhibition
of 5-LO. In effect, 5-LO activity in the presence of fully
saturated DPPG is ;8-fold lower than in the presence of
monounsaturated POPG. These data indicate that lipid acyl
chain unsaturation is a key modulator of 5-LO activity both
for zwitterionic and anionic lipid membranes.
To physically interpret the effects of lipids with varying
degrees of cis-unsaturation and the presence of cholesterol in
membranes on 5-LO activity, the ﬂuidity of membranes was
measured by GP of Laurdan incorporated in membranes at 1
mol %. Introduction of a single double bond in the sn-2 acyl
chain of the lipid, i.e., replacement of DPPC with POPC,
results in a sharp decrease in GP, indicating a signiﬁcant
increase in membrane ﬂuidity (Fig. 3). Membrane ﬂuidity
further increases with increasing degrees of lipid acyl chain
unsaturation, and reaches a plateau at four double bonds per
sn-2 chain of the lipid, corresponding to PAPC. The GP
value markedly increases upon introduction of 20 mol %
cholesterol in POPC membranes, indicating a decrease in
membrane ﬂuidity. Data of Figs. 1–3 provide strong evi-
dence for modulation of 5-LO activity by membrane ﬂuidity.
FIGURE 1 Activity of 5-LO increases with
an increasing degree of lipid cis-unsaturation
and decreases in the presence of cholesterol in
vesicle membranes. (A) Time dependence of
conversion of AA to 5-HPETE, as measured by
absorption at 238 nm. The buffer (speciﬁed in
Materials and Methods) contains 100 mM AA
and large unilamellar vesicles composed of 350
mM DPPC (1), POPC 1 20 mol % cholesterol
(2), POPC (3), PLPC (4), PAPC (5), and PDPC
(6). The reaction is initiated by adding 2.4mg/ml
5-LO, as indicated by the arrow. Measurements
are conducted at 22C. (B) A bar graph showing
the mean values and standard deviations of
5-LO activity in the presence of vesicles of dif-
ferent lipid compositions, as indicated. Exper-
imental conditions are as in A. Data shown in
B are averaged based on three independent
experiments.
FIGURE 2 Dependence of the speciﬁc activity of 5-LO on the content of
anionic lipids in ﬂuid (POPC/POPG) and solid (DPPC/DPPG) membranes.
Total lipid concentration was 350 mM in all cases, AA concentration was
100 mM, and 5-LO was added to a ﬁnal concentration of 2.4 mg/ml. The
buffer, method of 5-LO activity measurement, and other experimental con-
ditions are described in Materials and Methods.
FIGURE 3 Fluorescence emission spectra of 1 mol % Laurdan in vesicles
composed of DPPC (1), POPC1 20 mol % cholesterol (2), POPC (3), PLPC
(4), PAPC (5), and PDPC (6). The buffer contained 0.1 mM EGTA, 0.3 mM
CaCl2, and 50 mMTris-HCl (pH 7.5). Total lipid concentration was 100 mM
in 0.4-cm path-length quartz cuvettes. The excitation wavelength was 360
nm, and the temperature was 22C. The inset shows the dependence of GP
on the lipid composition, as speciﬁed in the main ﬁgure. The values of GP
were calculated as GP ¼ (F435  F500)/(F435 1 F500), where F435 and F500
are the Laurdan ﬂuorescence emission intensities at respective wavelengths.
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Dependence of membrane binding strength of
5-LO on membrane ﬂuidity
Our data indicate that 5-LO activity increases in the presence
of membranes with increasing ﬂuidity and reaches a saturat-
ing level with PAPC. To test the hypothesis that the increase
in 5-LO activity results from stronger binding of the enzyme
to more ﬂuid membranes, we measured the binding of 5-LO
to large unilamellar vesicles composed of DPPC, POPC,
PLPC, PAPC, and PDPC. Membrane binding of 5-LO was
studied using RET from tryptophans of 5-LO to 2 mol % Py-
PE in the membranes. When 5-LO was titrated with phos-
pholipid vesicles in the absence of an energy acceptor, Trp
ﬂuorescence decreased because of sample dilution (Fig. 4 A).
Titration of 5-LO with Py-PE-containing vesicles resulted in
a strong, lipid dose-dependent decrease in Trp ﬂuorescence
with concomitant increase in the pyrene emission, due to
RET (Fig. 4 B). Since RET is based on short-range (28 A˚ for
the Trp-pyrene pair) dipole-dipole interactions between
energy donors and acceptors (Lakowicz, 1999), the observed
effect indicates binding of 5-LO to vesicle membranes.
Analysis of binding isotherms (Fig. 5) yielded the dissoci-
ation constants and the numbers of lipid molecules per
protein binding site, as summarized in Table 1. These data
indicate that membrane binding afﬁnity of 5-LO increases
with increasing degrees of lipid acyl chain cis-unsaturation,
reaches the highest value for PAPC membranes (nD ¼ 4),
and then slightly decreases upon further increase in the
degree of lipid unsaturation, i.e., with PDPC membranes
(nD ¼ 6). Altogether, our ﬁndings delineate a correlation
between membrane ﬂuidity, membrane binding strength, and
activity of 5-LO.
The data of Table 1 indicate that the number of lipid
molecules per 5-LO binding site, N, decreases from 184 to
114 with increasing membrane ﬂuidity, which likely results
from larger cross-sectional area of lipids (AL) with higher
degree of unsaturation (Stillwell and Wassall, 2003). Using
the values of AL for all ﬁve lipids summarized in Table 1
(Stillwell and Wassall, 2003 and references therein), we
estimated that the membrane surface area per 5-LO binding
site is N 3 AL ¼ 9600 6 1250 A˚2.
Dependence of membrane insertion of 5-LO on
membrane ﬂuidity
The correlation between membrane ﬂuidity, membrane
binding afﬁnity, and activity of 5-LO suggests that the
enhancement of 5-LO activity by membrane ﬂuidity may
at least partly result from stronger binding of 5-LO to
membranes of higher ﬂuidity. However, other parameters of
5-LO-membrane interaction, such as the depth of insertion of
5-LO into the hydrophobic core of membranes, may also
contribute to 5-LO function. We have estimated the depth of
membrane insertion of the side chains of Trp residues of
5-LO by employing the quenching of Trp ﬂuorescence by
Br2PCs brominated at 6,7, or 9,10, or 11,12 positions of the
acyl chains, or by POPTC nitroxide spin-labeled at the polar
headgroup. In the presence of ﬂuid PAPC vesicles without
quenchers, Trp ﬂuorescence of 5-LO signiﬁcantly increased
(Fig. 6 A), indicating that some tryptophans of 5-LO ex-
perience less polar environment, apparently due to mem-
brane binding of 5-LO. (Unlike the experiments presented in
Fig. 4, in these experiments there was no dilution effect and
the increase in Trp emission intensity in the presence of
membranes could be seen directly.) Incorporation of Br2PCs
in PAPC vesicles resulted in quenching of 5-LO ﬂuorescence
by all three brominated lipids; the maximum quenching
occurred with vesicles containing 9,10-Br2PC (Fig. 6, A and
C). The distances of bromine atoms in Br2PCs brominated at
6,7, or 9,10, or 11,12 positions from the bilayer center have
been estimated to be 11.0, 8.3, and 6.5 A˚, respectively
(McIntosh and Holloway, 1987). Therefore, maximum
quenching of Trp ﬂuorescence by 9,10-Br2PC indicates
that the side chains of certain Trp residues of 5-LO bound to
FIGURE 4 Fluorescence emission spectra of
tryptophans of 5-LO in the absence and presence
of large unilamellar PAPC vesicles without (A) and
with (B) 2 mol % Py-PE. In both panels, increasing
darkness of the lines corresponds to an increase in
total lipid concentration from zero to 760 mM
(see Fig. 5). Decrease in Trp emission intensity in
A is due to dilution upon addition of stock vesicle
suspension. In B, Trp ﬂuorescence signiﬁcantly
decreases upon addition of Py-PE-containing
vesicles due to energy transfer from Trp of 5-LO
to Py-PE. The excitation wavelength was 290 nm,
and buffer and temperature were as in Fig. 3.
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PAPC membranes penetrate into the membrane hydrophobic
core nearly halfway to the membrane center. When PAPC
vesicles contained headgroup spin-labeled POPTC, Trp
ﬂuorescence was quenched to a larger extent than by any
of the brominated lipids (Fig. 6, A and C). This result indi-
cates that a larger fraction of tryptophans of 5-LO bound to
PAPC membranes are located at the membrane-water
interface compared to the fraction embedded into the lipid
hydrocarbon region.
In the presence of solid DPPC vesicles containing bro-
minated lipids, none of the Br2PCs quenched the Trp ﬂuo-
rescence of 5-LO (Fig. 6,B andC). However, Trp ﬂuorescence
was quenched by POPTC even more efﬁciently than in the
case of ﬂuid PAPC membranes, presumably because tryp-
tophans that embed into ﬂuid PAPCmembranes are located at
the membrane-water interface in the case of solid DPPC
membranes, thus increasing the total population of inter-
facially located tryptophans.Altogether, data of Fig. 6 suggest
that 5-LO is able to partially intrude into the hydrocarbon
region of ﬂuidmembranes, but in the case of solidmembranes
it interacts with the membrane surface without penetration
into its hydrophobic core. In conjunction with our data that
5-LO has stronger membrane binding afﬁnity and higher
activity in the presence of ﬂuidmembranes, these data suggest
that partial insertion of 5-LO into the membrane is likely to be
important for the enzyme function.
A model for membrane-bound 5-LO
The available data on membrane binding of human 5-LO, its
N-terminal putative b-barrel domain, and rabbit 15-LO allow
construction of a model of 5-LO bound to a phospholipid
membrane in the ﬂuid phase (Fig. 7). We have modeled the
structure of 5-LO using the structure of rabbit reticulocyte
15-LO as a template (Protein Data Bank entry, 1lox), which
shares 37% sequence identity and 57% similarity with 5-LO.
Homology modeling was achieved using the internet-based
SWISS-MODEL server (Schwede et al., 2003). The modeled
structure of 5-LO was positioned at the membrane surface
using the following criteria: 1), the symmetry axis of the
N-terminal b-barrel is oriented at ;45 with respect to the
membrane normal (Pande et al., 2004); 2), tryptophans 13,
75, and 102 likely interact with the membrane (Kulkarni
et al., 2002); 3), Trp181 of rabbit 15-LO, which corresponds
to Lys183 in the aligned 5-LO sequence, is likely to interact
with the membrane (Walther et al., 2002, 2004); and 4), at
least one Trp penetrates into the membrane to a depth of 8–9
A˚ from the membrane center (this work). Positioning of the
modeled 5-LO structure on the membrane surface according
to these constraints indicates that Trp75 likely penetrates into
the membrane deeper than any other residue, Trp13 inserts
into the hydrophobic part of the membrane, but not as deep
as Trp75, and Trp102 is closer to the membrane-water inter-
face. Note that Kulkarni et al. (2002) have shown that Trp102
was more important for the interaction of the b-barrel
domain of 5-LO with membranes than Trp13 or Trp75. This
is not necessarily in conﬂict with our model because trypto-
phans located at the polar headgroup/hydrocarbon boundary
of membranes can facilitate protein-membrane interactions
by means of both H-bonding and nonpolar interactions (Yau
et al., 1998) and thus may contribute to the interaction more
than totally embedded tryptophans that are not involved in
H-bonding with lipid carbonyl oxygens. Also, the truncated
b-barrel domain may not be oriented at the membrane sur-
face as the full-length protein. Lys183 is properly located to
make ionic and/or H-bonding interaction with the phosphate
group of membrane phospholipids. In Fig. 7, the residue
Arg411 is highlighted to indicate the putative site of entrance
of AA into the substrate binding cleft, because Gillmor et al.
(1997) have suggested that the corresponding residue in the
rabbit 15-LO sequence (Arg403) forms an ionic contact with
the carboxyl group of arachidonate during the initial step
FIGURE 5 Isotherms of 5-LO binding to vesicles composed of DPPC
(d), POPC (n), PLPC (:), PAPC (h), and PDPC (n). The data points are
obtained on the basis of the decrease in Trp ﬂuorescence emission intensity
due to energy transfer from Trp to Py-PE (2 mol % in vesicle membranes), as
measured in RET experiments (e.g., Fig. 4). The theoretical curves are simu-
lated through Eq. 1 using binding parameters summarized in Table 1.
TABLE 1 Parameters characterizing the interaction
of 5-LO with large unilamellar vesicles composed
of PCs of varying ﬂuidity
Lipid L1/2 (mM) KD (mM) N
DPPC 443.5 1.15 184
POPC 297.8 0.78 176
PLPC 199.2 0.56 157
PAPC 83.2 0.24 127
PDPC 92.0 0.32 114
Parameters include lipid concentrations corresponding to binding of 50% of
5-LO (L1/2), the dissociation constants (KD), and the numbers of lipids per
5-LO binding site (N). Lipids were composed of phosphatidylcholines with
varying degrees of sn-2 acyl chain unsaturation.
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of enzyme-substrate interaction. Also shown are the iron-
coordinating residues (histidines 367, 372, 550, and Ile673) to
identify the catalytic site of the enzyme (Zhang et al., 1992).
The model indicates that most surface-exposed tryptophans
of 5-LO are at the polar headgroup region of the membrane,
whereas Trp75 and Trp13 insert into the hydrophobic part of
the membrane. This agrees with the data indicating stronger
quenching of Trp ﬂuorescence by headgroup nitroxide-
labeled POPTC than by acyl chain-brominated lipids (Fig.
6). In the case of solid membranes, all tryptophans are
presumably located at the membrane-water interface without
membrane insertion, resulting in negligible quenching
FIGURE 7 A model for 5-LO bound to a phospho-
lipid membrane in the ﬂuid phase, constructed on the
basis of homology modeling and data on membrane
insertion and angular orientation of 5-LO. The protein
structure ismodeled usingSWISS-MODELon the basis
of rabbit 15-LO crystal structure as a template, and is
presented in a ribbon format. The N-terminal b-barrel
and the catalytic domains are shown in plum and aqua,
respectively. The mesh of gray spheres represents the
plane of the phosphate groups of phospholipid mole-
cules. Membrane-interacting and catalytically impor-
tant residues are shown in the ball-and-stick format
and are labeled by blue and red labels, respectively.
Tryptophans that insert into the membrane hydrocarbon
region are shown in yellow, and those located at the
membrane-water interface are shown in orange. Phe197
and Lys183, which interact with the membrane by non-
polar and ionic interactions, are shown in green and
purple, respectively. Arg411, which presumably forms
an ionic contactwith the carboxyl group of arachidonate
during the initial step of enzyme-substrate interaction, is
shown inmagenta.Residues involved in coordination of
the iron cofactor are colored according to the atom type.
Trp13, and partially Trp599 and Lys183, are underneath
the polar groups of lipids and can hardly be seen. His367
is hidden behind the helical ribbon. According to our
earlier results (Pande et al., 2004), the symmetry axis of
the N-terminal b-barrel domain is tilted at;45 with respect to the membrane normal, and the current data suggest that at least one Trp, most likely the Trp75,
inserts into the membrane as deep as 8–9 A˚ from the membrane center.
FIGURE 6 Fluorescence emission spectra of tryptophans of 5-LO in the absence and presence of large unilamellar vesicles composed of a ﬂuid lipid, PAPC
(A), or a solid lipid, DPPC (B). Only the top portions of spectra are shown to make differences between spectra more discernable. The spectra are numbered as
follows: 1, free 5-LO in buffer; 2, 5-LO with large unilamellar vesicles of PAPC (A) or DPPC (B); 3, 6,7-Br2PC-containing vesicles; 4, 9,10-Br2PC-containing
vesicles; 5, 11,12-Br2PC-containing vesicles; and 6, POPTC-containing vesicles. Numbering in A also applies to the same line types in B. (C) Summary of the
data obtained in three experiments (mean 6 SD). Open and solid bars apply to PAPC and DPPC membranes, respectively. When vesicles were present, the
total lipid concentration was 750 mM. Brominated lipids were present at 25 mol %, and POPTC at 15 mol %. Protein concentration was 0.24 mM. Excitation
was at 290 nm. The buffer and temperature were as in Fig. 3.
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by brominated lipids and stronger quenching by POPTC
(Fig. 6). The more ‘‘peripheral’’ binding of 5-LO to solid
membranes probably contributes to the decreased membrane
afﬁnity and lower activity of 5-LO (Figs. 1 and 5, Table 1).
DISCUSSION
Binding to intracellular membranes in vivo or to artiﬁcial
lipid membranes in vitro is an essential step in activation of
5-LO. Despite this, little is known about the mechanism of
interaction of 5-LO with membranes. No quantitative data on
5-LO-membrane interactions, such as binding constants or
5-LO-lipid binding stoichiometries, have been reported so
far, and the effects of physical properties of membranes, such
as membrane ﬂuidity, on membrane binding and activity of
5-LO are poorly understood. Previously we have conducted
a detailed analysis of the effects of lipid polar headgroups, as
well as of Ca21 and lipid concentrations, on 5-LO-mem-
brane interactions and 5-LO activity (Pande et al., 2004). In
this work, we concentrate on the effect of lipid acyl chain un-
saturation and membrane ﬂuidity on membrane binding
strength, membrane insertion, and activity of 5-LO. Our re-
sults provide unprecedented evidence that membrane ﬂuidity
is an important determinant for the membrane-binding mode
and activity of 5-LO.
To study the effect of lipid acyl chain unsaturation on the
membrane-binding mode and activity of 5-LO, we have
used PCs that contain a saturated palmitoyl chain at the sn-1
position, whereas the acyl chain at the sn-2 position was
either a palmitoyl (16:0), oleoyl (18:1), linoleoyl (18:2),
arachidonoyl (20:4), or docosahexaenoyl (22:6) residue
(shown in parentheses are the ratios of carbon atoms to
double bonds per chain). The choice of these lipids was
based on the fact that in major lipids of mammalian cell
membranes the sn-1 position is usually occupied by a sat-
urated chain, such as a palmitoyl residue, and the sn-2
position is most frequently occupied by one of the unsatu-
rated fatty acyl chains speciﬁed above (Albi et al., 1997;
Surette and Chilton, 1998; D’Antuono et al., 2000). Replace-
ment of fully saturated DPPC membranes by membranes
containing lipids with cis-unsaturated acyl chains results in
an ;3-fold increase in 5-LO activity. It is known that
membranes composed of DPPC are in the solid gel phase at
temperatures below 41C, whereas membranes composed of
POPC, PLPC, PAPC, or PDPC are in the ﬂuid, liquid
crystalline phase above 0C (Stubbs et al., 1981; Litman
et al., 1991; Stillwell and Wassall, 2003). Therefore, our data
indicate that the membrane-binding mode and activity of
5-LO are controlled by membrane ﬂuidity. Remarkably, the
maximum stimulatory effect on 5-LO activity was reached
with vesicles composed of PAPC. The fact that both the
membrane-binding strength and activity of 5-LO correlate
with Laurdan GP (Figs. 1, 3, and 5) indicates that the effect
of PAPC on 5-LO function is exerted through variation of
membrane ﬂuidity rather than speciﬁc 5-LO-PAPC inter-
actions. The activity of 5-LO in the presence of POPC mem-
branes containing 20 mol % cholesterol, which consist of
coexisting disordered and ordered phases (de Almeida et al.,
2003), is between activities measured in the presence of solid
(DPPC) and ﬂuid membranes (e.g., POPC). This is
consistent with the concept of modulation of 5-LO activity
by membrane ﬂuidity.
Our data indicate that the values of dissociation constants
(KD) of 5-LO for phospholipid membranes decrease from
1.15 to 0.24 mM upon an increase of the degree of lipid sn-2
acyl chain cis-unsaturation from zero to four, and undergoes
little change upon further increase in nD (Fig. 5 and Table 1).
This resembles the increase in 5-LO activity as a function of
membrane ﬂuidity (Fig. 1). Although quantitative data on 5-
LO binding to membranes are not available, surface plasmon
resonance experiments yielded a KD value of 0.6 nM for the
binding of the putative b-barrel domain of 5-LO to POPC
vesicles in the presence of 0.1 mM CaCl2 (Kulkarni et al.,
2002), which indicates much stronger binding of the b-barrel
domain compared to that of the full-length 5-LO deter-
mined in this work (0.78 mM). Differences in methods used
by Kulkarni et al. (2002) and in this work might partially ac-
count for discrepancies in measured dissociation constants.
On the other hand, this divergence is congruent with earlier
data showing that intracellular translocation of the N-terminal
b-barrel domain of 5-LO to the nuclear membrane was much
faster than that of the full-length protein (Chen and Funk,
2001). Furthermore, stronger membrane binding by itself
may not necessarily favor the enzyme function. It is possible
that the catalytic domain, while reducing the binding strength,
facilitates a deﬁned, productive mode binding of the enzyme
to the membrane surface.
The average area per 5-LO binding site at the membrane
surface is estimated to be Abs ¼ 9600 6 1250 A˚2. Using the
model of 5-LO (Fig. 7), we have determined that the protein
molecule can be roughly presented as a prolate ellipsoid of
revolution with semiaxes of 48 and 23 A˚. This would cor-
respond to a maximum cross-sectional area of p 3 48 3 23
 3500 A˚2, implying that Abs is ;2.7 times larger than the
maximum cross-sectional area of the molecule. Because of
the rotational freedom of membrane-bound protein mole-
cules around the membrane normal, the effective area per
membrane-bound 5-LO would be p 3 482  7200 A˚2. On
the other hand, even at the saturation of adsorption, there will
be ‘‘empty’’ surface area between membrane-bound protein
molecules. This means that upon binding of each protein
molecule, an area of (96 A˚)2  9200 A˚2 will become inac-
cessible to other protein molecules, which is in good agree-
ment with the experimentally determined effective area per
protein binding site of 9600 6 1250 A˚2.
Previous studies indicated that the N-terminal putative
b-barrel domain of 5-LO had;20 times stronger afﬁnity (in
terms of KD) for PC membranes than for membranes
containing 50 mol % of PG or PS (Kulkarni et al., 2002).
This led to the conclusion that increased afﬁnity of the
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b-barrel domain of 5-LO for PC versus anionic lipid mem-
branes dictates the localization of 5-LO to PC-rich nuclear
membranes (Kulkarni et al., 2002). However, the content of
anionic lipids in nuclear membranes is comparable to or even
higher than that of other cellular membranes (Khandwala
and Kasper, 1971; Neitcheva and Peeva, 1995; Surette and
Chilton, 1998; D’Santos et al., 1999, 2000; D’Antuono et al.,
2000). Also, PC is abundant not only in nuclear but in many
other membranes of eukaryotic cells (Hanahan, 1997;
Surette and Chilton, 1998; Mathews et al., 1999; D’Antuono
et al., 2000). For example, analysis of phospholipid content
in the plasma membrane, endoplasmic reticulum, and the
nuclear membrane of rat papillary cells indicated that PC was
the most abundant lipid (42–48 mol %) in all three cases
(D’Antuono et al., 2000). No signiﬁcant difference was
found in the PC content in nuclear membranes and whole-
cell lipid extract for human monocytes (Surette and Chilton,
1998). Therefore, preference of 5-LO for PC versus anionic
lipids cannot account for selective recruitment of 5-LO to
nuclear membranes.
Nuclear membranes are enriched in AA-containing lipids
more than other cellular membranes (Neufeld et al., 1985;
Capriotti et al., 1988; Albi et al., 1997; Surette and Chilton,
1998; D’Antuono et al., 2000). Thus, up to 48% of the total
cellular AA-containing lipids were found in the nuclear
membranes of various mammalian cell lines, including
leukemia cells (Surette and Chilton, 1998). In rat renal
papillary cells, the fraction of AA-containing lipids was 1.5
times higher, whereas the fraction of lipids with saturated
chains was 1.6 times lower in nuclear than in endoplasmic
reticulum membranes (D’Antuono et al., 2000). Large
fractions of AA-containing lipids result in elevated ﬂuidity
of nuclear membranes (Yu et al., 1996; Albi et al., 1997;
D’Antuono et al., 2000). This leads to a mechanism sug-
gesting that increased membrane ﬂuidity via high levels of
AA-containing lipids may be an important factor for local-
ization of 5-LO to nuclear membranes. Our data indeed
provide support for this mechanism by indicating that among
PCs with a palmitoyl residue in the sn-1 position and various
acyl chains in the sn-2 position, PAPC was the most efﬁcient
lipid in terms of facilitating membrane binding, membrane
insertion, and activity of 5-LO. Lipids with lower or higher
degrees of acyl chain unsaturation were not as efﬁcient as
PAPC. Taking into account that cytosolic phospholipase A2
(PLA2), as well as FLAP, are also colocalized to nuclear
membranes (Woods et al., 1993; Pouliot et al., 1996), this
mechanism would lead to a congregation of all enzymes,
regulators, and substrates for efﬁcient metabolism of AA-
containing lipids to leukotrienes.
Our model of 5-LO binding to a membrane in the ﬂuid
phase (Fig. 7) shows that partial insertion of 5-LO into the
hydrophobic core of the membrane may be required for
membrane-proximal location of the oriﬁce of the substrate-
binding pocket, marked by Arg411, and better access of 5-LO
to membrane-residing AA. Partial membrane insertion of
5-LO may also be necessary for positioning 5-LO at the
membrane surface in a productive mode, because the Ca21-
mediated electrostatic mechanism alone is apparently not
enough to do this.
Although details of membrane binding of 5-LO have not
been described before, membrane-binding modes of several
C2 domain-containing proteins or truncated C2 domains
have been assessed in the past. Cytosolic PLA2a, which
colocalizes with 5-LO at the nuclear membrane and produces
AA for eicosanoid production, was shown to considerably
penetrate into the hydrocarbon region of phospholipid
monolayers (Lichtenbergova et al., 1998). Certain residues
of the truncated C2-domain of cytosolic PLA2a penetrate
into the hydrocarbon region of membranes as deep as 5–10 A˚
below the plane of the lipid phosphate groups (Ball et al.,
1999; Malmberg et al., 2003). C2 domains of other
membrane-binding proteins, e.g., protein kinase Ca and
synaptotagmin I, penetrate into the polar headgroup region
of membranes but not into the hydrocarbon region as deep as
cytosolic PLA2a (Frazier et al., 2003; Kohout et al., 2003;
Rufener et al., 2005). The hydrophobic residues Phe70,
Leu71, Trp181, and Leu195of rabbit 15-LO, which are
clustered at the membrane-binding surface of 15-LO that
contains the substrate-binding pocket, were found to play
a major role in membrane anchoring of the protein, probably
involving partial membrane insertion (Walther et al., 2002,
2004). It seems likely that hydrophobic protein-membrane
interactions and partial membrane penetration constitute
a common feature of C2-domain-containing proteins. This
may be necessary to stabilize the membrane docking of these
proteins. It should be noted that all experiments with cy-
tosolic PLA2a, protein kinase Ca, and synaptotagmin I were
conducted using ﬂuid membranes composed of lipids
containing an oleic acid moiety at the sn-2 or at both
positions, and in experiments with 15-LO submitochondrial
particles were used (Walther et al., 2002, 2004). Thus, it was
not possible to assess the dependence of membrane insertion
on membrane ﬂuidity based on these studies. Our data,
however, clearly demonstrate that membrane insertion of
5-LO only occurs with ﬂuid, but not solid membranes, indi-
cating an important role of membrane ﬂuidity in modulating
the function of 5-LO and probably other enzymes that un-
dergo interfacial activation via membrane binding.
Finally, partial membrane insertion of 5-LO indicates
a resemblance between the membrane binding modes of
lipoxygenases and the other major class of enzymes involved
in eicosanoid biosynthesis, cyclooxygenases. The latter
enzymes are embedded in nuclear and perinuclear endoplas-
mic reticulum membranes as monotopic proteins (Spencer
et al., 1998; Marvin et al., 2000; Picot and Garavito, 1994;
Picot et al., 1997). Enrichment of these membranes with AA-
containing lipids probably facilitates membrane binding and
insertion of both cyclooxygenases and 5-LO through
increased membrane ﬂuidity and thus plays a regulatory
role in the biosynthesis of prostanoids and leukotrienes.
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